Inactive Instrument

News CanaQuest Medical Corp Other OTC

Equities

CA01551X1087

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

NHL Alumni Association Partners with CanaQuest and NEEKA Health to Conduct Studies for Anxiety and Quality of Life in Former NHL Players	23-10-31	CI
CanaQuest Medical Corp. cancelled the transaction announced on October 26, 2022	23-10-25	CI
CANAQUEST Announces Award of European Cannabinoid Patent	23-09-20	AQ
CanaQuest Medical Corp. Announces Award of European Cannabinoid Patent	23-09-19	CI
CanaQuest Awarded Best Global Medical Cannabinoid Development Company 2023 by UK-based Global Health and Pharma for their 8th Annual Healthcare and Pharmaceutical Program	23-07-27	AQ
CanaQuest Achieves Statistically Significant Reduction of Seizures for Epilepsy Compared to Standard CBD	22-12-08	CI
CanaQuest Medical Corp. announced a financing transaction	22-10-25	CI
CanaQuest Medical Corp. Launches Mentanine (R) (Cannabidiol + IP Formula) in the US	22-09-08	CI
CanaQuest Medical : Interim Consolidated Consolidated Financial Statements (unaudited) - June 30, 2022	22-08-08	PU
CanaQuest Medical : Attorney Letter	22-07-18	PU
CanaQuest Medical : Financial Statements (unaudited) - March 31, 2022	22-06-14	PU
CanaQuest Medical Corp. Appoints Rob Rinderman as New Director of Communications	21-04-07	CI
Canaquest Signs Medicinal Cannabis Education Partnership with the Canadian Cannabis Dispute Resolution Centre	21-03-11	CI
CANAQUEST MEDICAL CORP Announces New Production and Distribution Agreement with PurCann Pharma and SiliCycle Inc	21-02-02	CI
CANAQUEST MEDICAL CORP SECURES APPROVAL FOR LISTING ON THE OCMX™, AN ONLINE INVESTOR AND FINANCIAL CONNECTION PORTAL	20-09-17	GL
UPDATE: CANAQUEST MEDICAL CORP FILES PROVISIONAL PATENT FOR MENTANINE® - OMEGA-3 & PURE CANNABIDIOL (“CBD”) FORMULATION BOOSTING MENTAL HEALTH EFFICACY WHILE MINIMIZING CBD DOSAGE	20-07-14	GL
CANAQUEST MEDICAL CORP FILES PROVISIONAL PATENT FOR MENTANINE® - OMEGA-3 & PURE CANNABIDIOL (“CBD”) FORMULATION BOOSTING MENTAL HEALTH EFFICACY WHILE MINIMIZING CBD DOSAGE	20-07-14	GL
CanaQuest Medical Corp. Files A Provisional Cannabidiol/Omega-3 Patent, Trade Named Mentanine®	20-07-14	CI
Canaquest Medical Corp Awaits Health Canada Approval for Sales and Export of Mentabinol®	20-02-06	GL
CanaQuest Medical Corp Awaits Health Canada Approval for Sales and Export of Mentabinol®	20-02-06	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News CanaQuest Medical Corp Other OTC

Equities

CA01551X1087

Summary

Filters